Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice

Article English OPEN
Kamei, Junzo; Tanaka,Ken-ichiro; Sekino,Shota; Ikegami,Megumi; Ikeda,Hiroko; (2015)
  • Publisher: Dove Press
  • Journal: Journal of Experimental Pharmacology,volume 7,pages11-16 (issn: 1179-1454, eissn: 1179-1454)
  • Related identifiers: pmc: PMC4863530, doi: 10.2147/JEP.S79973
  • Subject: ProTx-II | A803467 | Nav1.7 | Original Research | Nav1.8 | Journal of Experimental Pharmacology | painful diabetic neuropathy

Ken-ichiro Tanaka,1,2, Shota Sekino,1 Megumi Ikegami,1 Hiroko Ikeda,1 Junzo Kamei11Department of Pathophysiology and Therapeutics, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo, Japan; 2Department of Endocrinology and Metabolism, Graduate Schoo... View more
  • References (40)
    40 references, page 1 of 4

    1. Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol. 2002;50:205-228.

    2. Kamei J, Ogawa M, Kasuya Y. Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic rats. Pharmacol Biochem Behav. 1990;35:473-475.

    3. Ohsawa M, Kamei J. Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice. Brain Res. 1999;833:278-281.

    4. Viola V, Newnham HH, Simpson RW. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. J Diabetes Complications. 2006;20:34-39.

    5. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly. 2010;140:297-306.

    6. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1988;1:9-11.

    7. Oskarsson P, Ljunggren JG, Lins PE. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexilitine Study Group. Diabetes Care. 1997;20:1594-1597.

    8. Kamei J, Saitoh A, Kasuya Y, Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice. Neurosci Lett. 1995;196:169-172.

    9. Suzuki N, Hasegawa-Moriyama M, TakahashiY, KamikuboY, Sakurai T, Inada E. Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation. Anesth Analg. 2011;113:941-946.

    10. Chahine M, Ziane R, Vijayaragavan K, Okamura Y. Regulation of Na v channels in sensory neurons. Trends Pharmacol Sci. 2005;26: 496-502.

  • Metrics
    No metrics available
Share - Bookmark